"COVID-19 Information: Virtua Health is committed to the health and safety of our community. New visitor guidelines are in effect throughout Virtua. We encourage the community to communicate via phone calls and video chat in order to stay connected. For details, please visit our website. Thank you for your cooperation."

During the past decade, Virtua Voorhees conducted 59 clinical trials. In the 10-year time frame, 59 clinical trials started and 73 clinical trials were completed, i.e. on average, 123.7% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 43 clinical trials were completed. i.e. 195.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Virtua Voorhees" #1 sponsor was "National Cancer Institute (NCI)" with 62 trials, followed by "SWOG Cancer Research Network" with 16 trials sponsored, "Alliance for Clinical Trials in Oncology" with 13 trials sponsored, "NRG Oncology" with 10 trials sponsored and "Gynecologic Oncology Group" with 10 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Virtua Voorhees" #1 collaborator was "National Cancer Institute (NCI)" with 64 trials as a collaborator, "NRG Oncology" with 26 trials as a collaborator, "NCIC Clinical Trials Group" with 8 trials as a collaborator, "Cancer and Leukemia Group B" with 7 trials as a collaborator and "SWOG Cancer Research Network" with 7 trials as a collaborator. Other collaborators include 33 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Virtua Voorhees" are "Stage IV Lung Cancer AJCC v8" (8 trials), "Recurrent Breast Carcinoma" (7 trials), "Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Invasive Breast Carcinoma" (6 trials) and "Stage IIA Fallopian Tube Cancer AJCC v6 and v7" (6 trials). Many other conditions were trialed in "Virtua Voorhees" in a lesser frequency.

Most popular intervention types in "Virtua Voorhees" are "Drug" (109 trials), "Other" (80 trials), "Biological" (52 trials), "Radiation" (35 trials) and "Procedure" (20 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (51 trials), "Quality-of-Life Assessment" (35 trials), "Paclitaxel" (27 trials), "Carboplatin" (26 trials) and "Cisplatin" (20 trials). Other intervention names were less common.

The vast majority of trials in "Virtua Voorhees" are 87 trials for "All" genders, 44 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Virtua Voorhees". undefined are not yet recruiting, 16 are recruiting, 62 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 34 completed trials in Virtua Voorhees, 2 suspended trials, and 18 terminated clinical trials to date.

Out of the total trials that were conducted in Virtua Voorhees, 2 "Phase 1" clinical trials were conducted, 47 "Phase 2" clinical trials and 87 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".